1.jpeg)
NITI Aayog member Dr. VK Paul has said that India's indigenous COVID-19 vaccine COVAXIN's trial data looked promising, and the vaccine could soon get emergency-use approval from the World Health Organization (WHO) soon. Reportedly, the vaccine's manufacturer, Bharat Biotech, also said that it has answered all queries and expects the approval to come by September end.
NITI Aayog member Dr. VK Paul has said that India's indigenous COVID-19 vaccine COVAXIN's trial data looked promising, and the vaccine could soon get emergency-use approval from the World Health Organization (WHO) soon. Reportedly, the vaccine's manufacturer, Bharat Biotech, also said that it has answered all queries and expects the approval to come by September end.
139.jpeg)
260.jpeg)
259.jpeg)
258.jpeg)
